Dopamine agonist switching in Parkinson's disease

Hosp Med. 2004 Apr;65(4):215-9. doi: 10.12968/hosp.2004.65.4.12734.

Abstract

There are a number of situations for patients with Parkinson's disease in which a safe and efficacious switch from treatment with one dopamine agonist to another may be required. This article explores reasons for making such a switch, and provides practical guidance on performing it.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Communication
  • Dopamine Agonists / adverse effects
  • Dopamine Agonists / therapeutic use*
  • Humans
  • Parkinson Disease / drug therapy*
  • Physician-Patient Relations

Substances

  • Dopamine Agonists